tradingkey.logo

Medtronic PLC

MDT
102.900USD
-0.060-0.06%
종가 02/06, 16:00ET시세는 15분 지연됩니다
131.92B시가총액
27.70P/E TTM

Medtronic PLC

102.900
-0.060-0.06%

자세한 내용은 Medtronic PLC 회사

Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.

Medtronic PLC 정보

종목 코드 MDT
회사 이름Medtronic PLC
상장일Nov 21, 1977
CEOMartha (Geoffrey S)
직원 수95000
유형Ordinary Share
회계 연도 종료Nov 21
주소Building Two Parkmore Business Park West
도시DUBLIN
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가Ireland
우편 번호H91 4K49
전화1135314381700
웹사이트https://www.medtronic.com/
종목 코드 MDT
상장일Nov 21, 1977
CEOMartha (Geoffrey S)

Medtronic PLC의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.90M
-1564.00%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President, President - Neuroscience Portfolio
Executive Vice President, President - Neuroscience Portfolio
548.17K
-439.00%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-3541.00%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
48.84K
+890.00%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Americas
Executive Vice President, President - Medical Surgical Portfolio and Americas
48.26K
-1371.00%
Mr. Craig Arnold
Mr. Craig Arnold
Lead Independent Director
Lead Independent Director
40.24K
+73.00%
Mr. Scott C. Donnelly
Mr. Scott C. Donnelly
Independent Director
Independent Director
21.71K
+192.00%
Dr. Elizabeth G. (Betsy) Nabel, M.D.
Dr. Elizabeth G. (Betsy) Nabel, M.D.
Independent Director
Independent Director
17.64K
+72.00%
Mr. Kevin E. Lofton
Mr. Kevin E. Lofton
Independent Director
Independent Director
8.19K
+72.00%
Mr. Thierry Jean Louis Pieton
Mr. Thierry Jean Louis Pieton
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
7.39K
-32060.00%
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.90M
-1564.00%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President, President - Neuroscience Portfolio
Executive Vice President, President - Neuroscience Portfolio
548.17K
-439.00%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-3541.00%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
48.84K
+890.00%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Americas
Executive Vice President, President - Medical Surgical Portfolio and Americas
48.26K
-1371.00%
Mr. Craig Arnold
Mr. Craig Arnold
Lead Independent Director
Lead Independent Director
40.24K
+73.00%

수익 분석

통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2026Q2
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Cardiac Rhythm & Heart Failure
1.82B
20.37%
Surgical & Endoscopy
1.68B
18.74%
Cranial & Spinal Technologies
1.30B
14.50%
Structural Heart & Aortic
956.00M
10.67%
Specialty Therapies
744.00M
8.30%
기타
2.46B
27.43%
지역별USD
이름
수익
비율
United States
4.52B
50.40%
Rest of World
4.41B
49.21%
Ireland
35.00M
0.39%
사업별
지역별
사업별USD
이름
수익
비율
Cardiac Rhythm & Heart Failure
1.82B
20.37%
Surgical & Endoscopy
1.68B
18.74%
Cranial & Spinal Technologies
1.30B
14.50%
Structural Heart & Aortic
956.00M
10.67%
Specialty Therapies
744.00M
8.30%
기타
2.46B
27.43%

주식 보유 통계

마지막 업데이트: Sat, Jan 31
마지막 업데이트: Sat, Jan 31
주주
주주 유형
주주
주주
비율
The Vanguard Group, Inc.
10.01%
BlackRock Institutional Trust Company, N.A.
5.18%
State Street Investment Management (US)
4.72%
JP Morgan Asset Management
2.92%
Capital Research Global Investors
2.39%
기타
74.78%
주주
주주
비율
The Vanguard Group, Inc.
10.01%
BlackRock Institutional Trust Company, N.A.
5.18%
State Street Investment Management (US)
4.72%
JP Morgan Asset Management
2.92%
Capital Research Global Investors
2.39%
기타
74.78%
주주 유형
주주
비율
Investment Advisor
46.16%
Investment Advisor/Hedge Fund
29.26%
Research Firm
4.20%
Pension Fund
2.39%
Bank and Trust
2.14%
Hedge Fund
1.41%
Sovereign Wealth Fund
1.37%
Family Office
0.38%
Insurance Company
0.38%
기타
12.31%

기관 주식 보유

마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
3753
1.13B
87.76%
-32.63M
2025Q3
3723
1.13B
88.20%
-2.77M
2025Q2
3762
1.12B
87.12%
-18.03M
2025Q1
3818
1.13B
88.15%
+2.18M
2024Q4
3768
1.12B
87.17%
+3.13M
2024Q3
3708
1.10B
85.63%
-24.55M
2024Q2
3725
1.11B
86.25%
-54.16M
2024Q1
3789
1.14B
85.95%
-7.87M
2023Q4
3780
1.13B
85.36%
-20.57M
2023Q3
3761
1.14B
85.37%
-14.93M
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
The Vanguard Group, Inc.
130.95M
10.21%
+4.49M
+3.55%
Nov 28, 2025
BlackRock Institutional Trust Company, N.A.
66.42M
5.18%
-1.42M
-2.10%
Sep 30, 2025
State Street Investment Management (US)
60.46M
4.72%
+625.99K
+1.05%
Sep 30, 2025
JP Morgan Asset Management
37.48M
2.92%
+11.18M
+42.48%
Sep 30, 2025
Capital Research Global Investors
30.69M
2.39%
-5.67M
-15.58%
Sep 30, 2025
Geode Capital Management, L.L.C.
27.65M
2.16%
-579.44K
-2.05%
Sep 30, 2025
MFS Investment Management
19.44M
1.52%
+75.05K
+0.39%
Sep 30, 2025
Norges Bank Investment Management (NBIM)
16.44M
1.28%
+1.87M
+12.83%
Jun 30, 2025
Managed Account Advisors LLC
14.98M
1.17%
+1.21M
+8.79%
Sep 30, 2025
BlackRock Financial Management, Inc.
14.32M
1.12%
-1.30M
-8.33%
Sep 30, 2025
더 보기

관련 ETF

마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
Absolute Select Value ETF
4.89%
iShares U.S. Medical Devices ETF
4.4%
iShares Health Innovation Active ETF
4.26%
Cullen Enhanced Equity Income ETF
4.24%
USCF Dividend Income Fund
3.59%
JPMorgan Healthcare Leaders ETF
3.22%
Madison Dividend Value ETF
3.08%
Tema Heart & Health ETF
2.98%
Global X Aging Population ETF
2.98%
WisdomTree US AI Enhanced Value Fund
2.86%
더 보기
Absolute Select Value ETF
비율4.89%
iShares U.S. Medical Devices ETF
비율4.4%
iShares Health Innovation Active ETF
비율4.26%
Cullen Enhanced Equity Income ETF
비율4.24%
USCF Dividend Income Fund
비율3.59%
JPMorgan Healthcare Leaders ETF
비율3.22%
Madison Dividend Value ETF
비율3.08%
Tema Heart & Health ETF
비율2.98%
Global X Aging Population ETF
비율2.98%
WisdomTree US AI Enhanced Value Fund
비율2.86%

주식 배당금

지난 5년 동안 총 17.37B USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
Dec 04, 2025
MDT.NB Interim Cash Dividend of gross USD 0.71 paid on Jan 16, 2026 going ex on Dec 26, 2025 with reinvestment option
Dec 26, 2025
Jan 16, 2026
Dec 26, 2025
Aug 14, 2025
MDT.NB Interim Cash Dividend of gross USD 0.71 paid on Oct 17, 2025 going ex on Sep 26, 2025 with reinvestment option
Sep 26, 2025
Oct 17, 2025
Sep 26, 2025
May 21, 2025
MDT.NB Interim Cash Dividend of gross USD 0.71 paid on Jul 11, 2025 going ex on Jun 27, 2025 with reinvestment option
Jun 27, 2025
Jul 11, 2025
Jun 27, 2025
Mar 06, 2025
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Apr 11, 2025 going ex on Mar 28, 2025 with reinvestment option
Mar 28, 2025
Apr 11, 2025
Mar 28, 2025
Dec 05, 2024
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jan 10, 2025 going ex on Dec 27, 2024 with reinvestment option
Dec 27, 2024
Jan 10, 2025
Dec 27, 2024
Aug 16, 2024
MDT.NB Final Cash Dividend of gross USD 0.7 paid on Oct 11, 2024 going ex on Sep 27, 2024 with reinvestment option
Sep 27, 2024
Oct 11, 2024
Sep 27, 2024
May 23, 2024
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jul 12, 2024 going ex on Jun 28, 2024 with reinvestment option
Jun 28, 2024
Jul 12, 2024
Jun 28, 2024
Mar 07, 2024
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Apr 12, 2024 going ex on Mar 21, 2024 with reinvestment option
Mar 22, 2024
Apr 12, 2024
Mar 21, 2024
Dec 07, 2023
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jan 12, 2024 going ex on Dec 19, 2023
Dec 20, 2023
Jan 12, 2024
Dec 19, 2023
Aug 17, 2023
MDT.NB Final Cash Dividend of gross USD 0.69 paid on Oct 13, 2023 going ex on Sep 21, 2023 with reinvestment option
Sep 22, 2023
Oct 13, 2023
Sep 21, 2023
더 보기

주식 분할

날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
KeyAI